Form 10-Q IsoRay, Inc. For: Mar 31

Go back to Form 10-Q IsoRay, Inc. For: Mar 31

Maxim Still Bullish on IsoRay (ISR) Following Q1 Results; More Physicians Adopting Cesium-131

May 18, 2015 2:51 PM EDT

Maxim Group affirms IsoRay (NYSE: ISR) with a Buy rating and $5 price target after the company reported reported Q3 EPS of ($0.02) with revenue of $1.16, versus EPS of ($0.05) and revenue of $1.13 million reported in the same period last year.

Analyst Jason Kolbert noted,... More

IsoRay (ISR) Reports Q3 Loss of $0.02/Share

May 18, 2015 8:47 AM EDT

IsoRay (NYSE: ISR) reported Q3 EPS of ($0.02), versus ($0.05) reported last year. Revenue for the quarter came in at $1.16 million, versus $1.13 million reported last year.

For earnings history and earnings-related data on IsoRay (ISR) click here.

... More